Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
A major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostat...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/20/18/5287 |
id |
doaj-83921677d4dc48c9807d4260f8e84e1c |
---|---|
record_format |
Article |
spelling |
doaj-83921677d4dc48c9807d4260f8e84e1c2020-11-25T03:28:47ZengMDPI AGSensors1424-82202020-09-01205287528710.3390/s20185287Catalytic Gold Deposition for Ultrasensitive of Prostate Specific AntigenLaura Cid-Barrio0Jorge Ruiz Encinar1José Manuel Costa-Fernández2Department of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainDepartment of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainDepartment of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainA major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostate-specific antigen (PSA), a well-recognized cancer biomarker. A sandwich type immunosensor has been developed employing a detection antibody labeled with inorganic nanoparticles acting as tags for further indirect quantification of the analyte. The required high sensitivity is then achieved through a controlled gold deposition on the nanoparticle surface, carried out after completing the recognition step of the immunoassay, thus effectively amplifying the size of the nanoparticles from nm to µm range. Due to such an amplification procedure, quantification of the biomolecule could be carried out directly on the immunoassay plates using confocal microscopy for measurement of the reflected light produced by gold-enlarged nanostructures. The high specificity of the immunoassay was demonstrated with the addition of a major abundant protein in serum (albumin) at much higher concentrations. An extremely low detection limit for PSA quantification (LOD of 1.1 fg·mL<sup>−1</sup> PSA) has been achieved. Such excellent LOD is 2–3 orders of magnitude lower than the clinically relevant PSA levels present in biological samples (4–10 ng·mL<sup>−1</sup>) and even to monitor eventual recurrence after clinical treatment of a prostate tumor (0.1 ng·mL<sup>−1</sup>). In fact, the broad dynamic range obtained (4 orders of magnitude) would allow the PSA quantification of diverse samples at very different relevant levels.https://www.mdpi.com/1424-8220/20/18/5287quantum dotsimmunoassaybiomarkernanotechnologysignal amplification |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Laura Cid-Barrio Jorge Ruiz Encinar José Manuel Costa-Fernández |
spellingShingle |
Laura Cid-Barrio Jorge Ruiz Encinar José Manuel Costa-Fernández Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen Sensors quantum dots immunoassay biomarker nanotechnology signal amplification |
author_facet |
Laura Cid-Barrio Jorge Ruiz Encinar José Manuel Costa-Fernández |
author_sort |
Laura Cid-Barrio |
title |
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen |
title_short |
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen |
title_full |
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen |
title_fullStr |
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen |
title_full_unstemmed |
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen |
title_sort |
catalytic gold deposition for ultrasensitive of prostate specific antigen |
publisher |
MDPI AG |
series |
Sensors |
issn |
1424-8220 |
publishDate |
2020-09-01 |
description |
A major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostate-specific antigen (PSA), a well-recognized cancer biomarker. A sandwich type immunosensor has been developed employing a detection antibody labeled with inorganic nanoparticles acting as tags for further indirect quantification of the analyte. The required high sensitivity is then achieved through a controlled gold deposition on the nanoparticle surface, carried out after completing the recognition step of the immunoassay, thus effectively amplifying the size of the nanoparticles from nm to µm range. Due to such an amplification procedure, quantification of the biomolecule could be carried out directly on the immunoassay plates using confocal microscopy for measurement of the reflected light produced by gold-enlarged nanostructures. The high specificity of the immunoassay was demonstrated with the addition of a major abundant protein in serum (albumin) at much higher concentrations. An extremely low detection limit for PSA quantification (LOD of 1.1 fg·mL<sup>−1</sup> PSA) has been achieved. Such excellent LOD is 2–3 orders of magnitude lower than the clinically relevant PSA levels present in biological samples (4–10 ng·mL<sup>−1</sup>) and even to monitor eventual recurrence after clinical treatment of a prostate tumor (0.1 ng·mL<sup>−1</sup>). In fact, the broad dynamic range obtained (4 orders of magnitude) would allow the PSA quantification of diverse samples at very different relevant levels. |
topic |
quantum dots immunoassay biomarker nanotechnology signal amplification |
url |
https://www.mdpi.com/1424-8220/20/18/5287 |
work_keys_str_mv |
AT lauracidbarrio catalyticgolddepositionforultrasensitiveofprostatespecificantigen AT jorgeruizencinar catalyticgolddepositionforultrasensitiveofprostatespecificantigen AT josemanuelcostafernandez catalyticgolddepositionforultrasensitiveofprostatespecificantigen |
_version_ |
1724582772323909632 |